Betalactamase-producing microorganisms in recurrent tonsillitis.

Area of Science:

• Microbiology
• Infectious Diseases
• Pharmacology

Background:

• Recurrent tonsillitis is a common condition often associated with bacterial colonization.
• The presence of betalactamase-producing microorganisms complicates treatment strategies.
• Understanding the microbial landscape in recurrent tonsillitis is crucial for effective management.

Purpose of the Study:

• To investigate the prevalence of betalactamase-producing microorganisms in patients with recurrent tonsillitis.
• To evaluate the in vivo efficacy of phenoxymethylpenicillin, clindamycin, and tinidazole against these pathogens.

Main Methods:

• Microbiological analysis of 167 patients with recurrent tonsillitis.
• Assessment of betalactamase production in isolated microorganisms.
• Clinical evaluation of antibiotic treatment with phenoxymethylpenicillin, clindamycin, and tinidazole.

Main Results:

• Betalactamase-producing microorganisms were found in 73% of patients.
• Clindamycin demonstrated broad-spectrum efficacy, eradicating Staphylococcus aureus, streptococci, Bacteroides, and Fusobacteria.
• Phenoxymethylpenicillin showed limited efficacy against streptococci, while tinidazole primarily affected anaerobes; Haemophilus species were resistant to both.

Conclusions:

• Clindamycin is a highly effective treatment option for recurrent tonsillitis caused by a wide range of bacteria, including betalactamase producers.
• Phenoxymethylpenicillin and tinidazole have limited utility in this patient population due to resistance patterns.
• Targeted antibiotic selection based on microbial susceptibility is essential for managing recurrent tonsillitis.